PRAX

Praxis Precision Medicines Inc — AI technical analysis, September 2026
NYSE/NASDAQ · Biotechnology
Technical Signal
BUY
Technical score 90/100
Last price: $312.90  ·  52W range $37.24 – $392.70
Short answer

Should you buy PRAX right now? Stockgaide's algorithm rates PRAX as BUY (technical signal), with a technical score of 90/100 at a last price of $312.90. The 50-day average is above the 200-day average, and RSI sits at 27.4. Wall Street's consensus rating is 1.84/5.

Technical signal details

Rule-based read from price and momentum indicators only — the score behind the technical signal above. Technical score: 90/100 (BUY).

Technical indicators

RSI (14)
27.4
SMA 50
340.11
SMA 200
311.90
MACD hist
-5.097

Fundamentals & Wall Street

Market Cap
$9.23B
P/E (TTM)
Dividend Yield
Analyst Consensus
1.84 / 5

Analyst ratings: 22 Buy · 2 Hold · 1 Sell (1 = Strong Buy, 5 = Strong Sell)

PRAX stock: frequently asked questions

Is PRAX a buy right now?

Stockgaide's AI currently rates PRAX as BUY (technical signal), with a technical score of 90 out of 100 at a last price of $312.90. This is educational content, not investment advice.

Is PRAX in an uptrend?

PRAX's 50-day moving average (340.11) is above its 200-day moving average (311.90), which points to a medium-term uptrend.

What is PRAX's RSI today?

PRAX has a 14-day RSI of 27.4, which places it in oversold territory (above 70 is overbought, below 30 is oversold).

What do analysts say about PRAX?

Wall Street analysts covering PRAX have a consensus rating of 1.84 out of 5 (1 = Strong Buy), meaning they lean Buy — 22 Buy · 2 Hold · 1 Sell.

Where is PRAX trading in its 52-week range?

PRAX last traded at $312.90, against a 52-week range of $37.24 to $392.70 — about 78% of the way up that range.

Get the full AI analysis of PRAX

Price targets, fundamentals deep-dive and an AI-written report — free, no signup.

Analyze PRAX now →
Data updated Sep 15, 2026 · refreshed daily